Cell Dissociation Market by Product (Enzymatic (Collagenase  Trypsin  DNase  Elastase) Non-enzymatic)  Type (Tissue Dissociation)  Tissue (Connective  Epithelial)  End User (Pharmaceutical  Research Institutes) - Global Forecast to 2023

Cell Dissociation Market by Product (Enzymatic (Collagenase Trypsin DNase Elastase) Non-enzymatic) Type (Tissue Dissociation) Tissue (Connective Epithelial) End User (Pharmaceutical Research Institutes) - Global Forecast to 2023

MarketsandMarkets | ID: 1524192706602 | Published at: 2018-03-28 | Pages: 116

  • €4.785,63


“The global cell dissociation market is projected to grow at a CAGR of 12.8% during the forecast period”
The cell dissociation market is expected to reach USD 440.5 million by 2023 from USD 241.2 million in 2018, at a CAGR of 12.8%. Factors driving the growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing lucrative opportunities for the players operating in the cell dissociation market.
“The non-enzymatic products segment is anticipated to grow at the fastest rate in the next five years”
Based on product, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories market. Among all, the non-enzymatic product segment is estimated to grow at the highest CAGR during the forecast period. This can be primarily attributed to advantages such as ready to use and non-toxic in nature.
“Tissue dissociation type segment is expected to dominate the cell dissociation market during the forecast period”
On the basis of type, the market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzymatic products and instruments & accessories in the pharmaceutical & biotechnology companies is the major driving factor for this segment.
“Asia Pacific is estimated to grow at the highest CAGR during the study period”
Geographically, the cell dissociation market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to infrastructural developments in the life sciences industry, rising government investments for chronic disease research, and presence of emerging economies such as China and India.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1–35%, Tier 2–22% and Tier 3- 43%
• By Designation: C level–15%, Director level–32%, Others–53%
• By Region: North America–34%, Europe–25%, Asia Pacific–23%, Rest of the World–18%

The key players in the cell dissociation market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).

Research Coverage:
The report analyses the cell dissociation market by product, tissue, type, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.
Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the cell dissociation market
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell dissociation market
• Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the cell dissociation market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell dissociation products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell dissociation market

TABLE OF CONTENTS

1 INTRODUCTION 11

  • 1.1 OBJECTIVES OF THE STUDY 11
  • 1.2 MARKET DEFINITION 11
  • 1.3 MARKET SCOPE 12
    • 1.3.1 MARKETS COVERED 12
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 13
  • 1.4 CURRENCY 13
  • 1.5 LIMITATIONS 13
  • 1.6 STAKEHOLDERS 13
    2 RESEARCH METHODOLOGY 14
  • 2.1 RESEARCH DATA 15
    • 2.1.1 SECONDARY DATA 15
      • 2.1.1.1 Key data from secondary sources 15
    • 2.1.2 PRIMARY DATA 16
      • 2.1.2.1 Key data from primary sources 17
  • 2.2 MARKET SIZE ESTIMATION 17
    • 2.2.1 BOTTOM-UP APPROACH 18
    • 2.2.2 TOP-DOWN APPROACH 18
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 19
  • 2.4 ASSUMPTIONS FOR THE STUDY 21
    3 EXECUTIVE SUMMARY 22
    4 PREMIUM INSIGHTS 26
  • 4.1 CELL DISSOCIATION MARKET OVERVIEW 26
  • 4.2 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT & COUNTRY 27
  • 4.3 CELL DISSOCIATION MARKET, BY REGION 28
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL DISSOCIATION MARKET (MAJOR COUNTRIES) 29
    5 MARKET OVERVIEW 30
  • 5.1 INTRODUCTION 30
  • 5.2 MARKET DYNAMICS 30
    • 5.2.1 DRIVERS 31
      • 5.2.1.1 Increasing R&D activities in biopharmaceutical companies 31
      • 5.2.1.2 Favorable funding scenario for cancer research 31
    • 5.2.2 OPPORTUNITY 32
      • 5.2.2.1 Growth opportunities in emerging markets 32
    • 5.2.3 TRENDS 32
      • 5.2.3.1 Emergence of advanced tissue dissociation enzyme products 32
      • 5.2.3.2 Acceptance of enzyme-free dissociation products over enzymatic dissociation products 33
        6 CELL DISSOCIATION MARKET, BY PRODUCT 34
  • 6.1 INTRODUCTION 35
  • 6.2 ENZYMATIC DISSOCIATION PRODUCTS 36
    • 6.2.1 COLLAGENASE 36
    • 6.2.2 TRYPSIN 37
    • 6.2.3 PAPAIN 38
    • 6.2.4 ELASTASE 39
    • 6.2.5 DNASE 40
    • 6.2.6 HYALURONIDASE 41
    • 6.2.7 OTHER ENZYMES 42
  • 6.3 NON-ENZYMATIC DISSOCIATION PRODUCTS 43
  • 6.4 INSTRUMENTS & ACCESSORIES 45
    7 CELL DISSOCIATION MARKET, BY TISSUE TYPE 46
  • 7.1 INTRODUCTION 47
  • 7.2 CONNECTIVE TISSUE 48
  • 7.3 EPITHELIAL TISSUE 49
  • 7.4 OTHER TISSUE 50
    8 CELL DISSOCIATION MARKET, BY APPLICATION 51
  • 8.1 INTRODUCTION 52
  • 8.2 TISSUE DISSOCIATION 52
  • 8.3 CELL DETACHMENT 53
    9 CELL DISSOCIATION MARKET, BY END USER 54
  • 9.1 INTRODUCTION 55
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 56
  • 9.3 RESEARCH & ACADEMIC INSTITUTES 57
  • 9.4 OTHER END USERS 59
    10 CELL DISSOCIATION MARKET, BY REGION 61
  • 10.1 INTRODUCTION 62
  • 10.2 NORTH AMERICA 63
    • 10.2.1 US 66
    • 10.2.2 CANADA 68
  • 10.3 EUROPE 70
  • 10.4 ASIA PACIFIC 72
    • 10.4.1 JAPAN 75
    • 10.4.2 CHINA 77
    • 10.4.3 INDIA 78
    • 10.4.4 REST OF ASIA PACIFIC 80
  • 10.5 REST OF THE WORLD 82
    11 COMPETITIVE LANDSCAPE 84
  • 11.1 OVERVIEW 84
  • 11.2 MARKET RANKING ANALYSIS 85
  • 11.3 COMPETITIVE SCENARIO 86
    • 11.3.1 EXPANSIONS 86
    • 11.3.2 ACQUISITIONS 86
    • 11.3.3 AGREEMENTS 86
      12 COMPANY PROFILES 87
      (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
  • 12.1 BD 87
  • 12.2 THERMO FISHER SCIENTIFIC 89
  • 12.3 F. HOFFMANN-LA ROCHE LTD. 91
  • 12.4 GE HEALTHCARE 93
  • 12.5 MERCK KGAA 95
  • 12.6 ATCC 98
  • 12.7 HIMEDIA LABORATORIES 99
  • 12.8 PAN-BIOTECH 100
  • 12.9 MILTENYI BIOTEC 101
  • 12.10 STEMCELL TECHNOLOGIES 102

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 104

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS 104
  • 13.2 DISCUSSION GUIDE 105
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 108
  • 13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 110
  • 13.5 AVAILABLE CUSTOMIZATIONS 112
  • 13.6 RELATED REPORTS 113
  • 13.7 AUTHOR DETAILS 114

LIST OF TABLES

TABLE 1 R&D EXPENDITURE OF MAJOR BIOPHARMACEUTICAL COMPANIES, 2015 VS. 2016 31
TABLE 2 CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 35
TABLE 3 ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 36
TABLE 4 COLLAGENASE MARKET, BY REGION, 2016–2023 (USD MILLION) 37
TABLE 5 NORTH AMERICA: COLLAGENASE MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 37
TABLE 6 TRYPSIN MARKET, BY REGION, 2016–2023 (USD MILLION) 38
TABLE 7 NORTH AMERICA: TRYPSIN MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 38
TABLE 8 PAPAIN MARKET, BY REGION, 2016–2023 (USD MILLION) 39
TABLE 9 NORTH AMERICA: PAPAIN MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 39
TABLE 10 ELASTASE MARKET, BY REGION, 2016–2023 (USD MILLION) 40
TABLE 11 NORTH AMERICA: ELASTASE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 40
TABLE 12 DNASE MARKET, BY REGION, 2016–2023 (USD MILLION) 40
TABLE 13 NORTH AMERICA: DNASE MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 41
TABLE 14 HYALURONIDASE MARKET, BY REGION, 2016–2023 (USD MILLION) 41
TABLE 15 NORTH AMERICA: HYALURONIDASE MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 42
TABLE 16 OTHER ENZYMES MARKET, BY REGION, 2016–2023 (USD MILLION) 42
TABLE 17 NORTH AMERICA: OTHER ENZYMES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 43
TABLE 18 NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY REGION,
2016–2023 (USD MILLION) 44
TABLE 19 NORTH AMERICA: NON-ENZYMATIC DISSOCIATION PRODUCTS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 44
TABLE 20 INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2016–2023 (USD MILLION) 45
TABLE 21 NORTH AMERICA: INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 45
TABLE 22 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2016–2023 (USD MILLION) 47
TABLE 23 CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUE, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 24 CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUE, BY REGION,
2016–2023 (USD MILLION) 49
TABLE 25 CELL DISSOCIATION MARKET FOR OTHER TISSUE, BY REGION,
2016–2023 (USD MILLION) 50
TABLE 26 CELL DISSOCIATION MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 52
TABLE 27 TISSUE DISSOCIATION MARKET, BY REGION, 2016–2023 (USD MILLION) 53
TABLE 28 CELL DETACHMENT MARKET, BY REGION, 2016–2023 (USD MILLION) 53
TABLE 29 CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 55
TABLE 30 CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 56
TABLE 31 NORTH AMERICA: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 32 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 57
TABLE 33 CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES,
BY REGION, 2016–2023 (USD MILLION) 57
TABLE 34 NORTH AMERICA: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 35 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 36 CELL DISSOCIATION MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 59
TABLE 37 NORTH AMERICA: CELL DISSOCIATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 38 ASIA PACIFIC: CELL DISSOCIATION MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 39 CELL DISSOCIATION MARKET, BY REGION, 2016–2023 (USD MILLION) 62
TABLE 40 NORTH AMERICA: CELL DISSOCIATION MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 65
TABLE 41 NORTH AMERICA: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 65
TABLE 42 NORTH AMERICA: ENZYMATIC DISSOCIATION PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 66
TABLE 43 NORTH AMERICA: CELL DISSOCIATION MARKET, BY END USER,
2016–2023 (USD MILLION) 66
TABLE 44 US: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 67
TABLE 45 US: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 67
TABLE 46 US: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 68
TABLE 47 CANADA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 68
TABLE 48 CANADA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 69
TABLE 49 CANADA: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 69
TABLE 50 EUROPE: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 70
TABLE 51 EUROPE: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 71
TABLE 52 EUROPE: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 71
TABLE 53 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 74
TABLE 54 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 74
TABLE 55 ASIA PACIFIC: ENZYMATIC DISSOCIATION PRODUCTS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 74
TABLE 56 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY END USER,
2016–2023 (USD MILLION) 75
TABLE 57 JAPAN: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 76
TABLE 58 JAPAN: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 76
TABLE 59 JAPAN: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 77
TABLE 60 CHINA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 77
TABLE 61 CHINA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 78
TABLE 62 CHINA: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 78
TABLE 63 INDIA: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 79
TABLE 64 INDIA: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 79
TABLE 65 INDIA: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 80
TABLE 66 ROAPAC: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 80
TABLE 67 ROAPAC: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 81
TABLE 68 ROAPAC: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 81
TABLE 69 ROW: CELL DISSOCIATION MARKET, BY PRODUCT, 2016–2023 (USD MILLION) 82
TABLE 70 ROW: ENZYMATIC DISSOCIATION PRODUCTS MARKET, BY TYPE,
2016–2023 (USD MILLION) 83
TABLE 71 ROW: CELL DISSOCIATION MARKET, BY END USER, 2016–2023 (USD MILLION) 83
TABLE 72 TOP 5 COMPANIES IN THE CELL DISSOCIATION MARKET 85
TABLE 73 EXPANSIONS, 2014–2017 86
TABLE 74 ACQUISITIONS, 2014–2017 86
TABLE 75 AGREEMENTS, 2014–2017 86


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 14
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 16
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 18
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 DATA TRIANGULATION METHODOLOGY 20
FIGURE 6 CELL DISSOCIATION MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 22
FIGURE 7 CELL DISSOCIATION MARKET, BY TISSUE TYPE, 2018 VS. 2023 (USD MILLION) 23
FIGURE 8 CELL DISSOCIATION MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 23
FIGURE 9 CELL DISSOCIATION MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 24
FIGURE 10 CELL DISSOCIATION MARKET, BY REGION, 2018 VS. 2023 (USD MILLION) 24
FIGURE 11 INCREASING R&D INVESTMENTS BY PHARMA COMPANIES, AND RISING FUNDING FOR CHRONIC DISEASE RESEARCH TO DRIVE MARKET GROWTH 26
FIGURE 12 ENZYMATIC DISSOCIATION PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 27
FIGURE 13 NORTH AMERICA EXPECTED TO REGISTER THE HIGHEST MARKET SHARE IN 2017 28
FIGURE 14 INDIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 29
FIGURE 15 CELL DISSOCIATION MARKET: DRIVERS, OPPORTUNITIES, AND TRENDS 30
FIGURE 16 ENZYMATIC DISSOCIATION PRODUCTS TO DOMINATE THE CELL DISSOCIATION MARKET DURING THE FORECAST PERIOD 35
FIGURE 17 CONNECTIVE TISSUE SEGMENT WILL CONTINUE TO DOMINATE THE CELL DISSOCIATION MARKET IN 2023 47
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL DISSOCIATION MARKET DURING THE FORECAST PERIOD 55
FIGURE 19 NORTH AMERICA TO DOMINATE THE GLOBAL CELL DISSOCIATION MARKET
IN 2018 62
FIGURE 20 NORTH AMERICA: CELL DISSOCIATION MARKET SNAPSHOT 64
FIGURE 21 ASIA PACIFIC: CELL DISSOCIATION MARKET SNAPSHOT 73
FIGURE 22 EXPANSIONSKEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2014 AND 2017 84
FIGURE 23 BD: COMPANY SNAPSHOT (2017) 87
FIGURE 24 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016) 89
FIGURE 25 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2017) 91
FIGURE 26 GE HEALTHCARE: COMPANY SNAPSHOT (2017) 93
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2016) 95

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!